Quince Therapeutics Stock Forward View
| QNCX Stock | USD 0.13 0.01 7.14% |
Quince Stock outlook is based on your current time horizon.
At this time, the RSI of Quince Therapeutics' share price is approaching 30 indicating that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Quince Therapeutics, making its price go up or down. Momentum 30
Sell Stretched
Oversold | Overbought |
EPS Estimate Next Quarter (0.21) | EPS Estimate Current Year (1.16) | EPS Estimate Next Year (1.17) | Wall Street Target Price 5 | EPS Estimate Current Quarter (0.22) |
Using Quince Therapeutics hype-based prediction, you can estimate the value of Quince Therapeutics from the perspective of Quince Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Quince Therapeutics using Quince Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Quince using crowd psychology based on the activity and movement of Quince Therapeutics' stock price.
Quince Therapeutics Short Interest
An investor who is long Quince Therapeutics may also wish to track short interest. As short interest increases, investors should be becoming more worried about Quince Therapeutics and may potentially protect profits, hedge Quince Therapeutics with its derivative instruments, or be ready for some potential downside.
200 Day MA 1.8511 | Short Percent 0.0376 | Short Ratio 0.51 | Shares Short Prior Month 3.5 M | 50 Day MA 2.3524 |
Quince Relative Strength Index
The Naive Prediction forecasted value of Quince Therapeutics on the next trading day is expected to be 1.13 with a mean absolute deviation of 0.40 and the sum of the absolute errors of 24.88.Quince Therapeutics Hype to Price Pattern
Investor biases related to Quince Therapeutics' public news can be used to forecast risks associated with an investment in Quince. The trend in average sentiment can be used to explain how an investor holding Quince can time the market purely based on public headlines and social activities around Quince Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Quince Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Quince Therapeutics.
Quince Therapeutics Implied Volatility | 4.41 |
Quince Therapeutics' implied volatility exposes the market's sentiment of Quince Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Quince Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Quince Therapeutics stock will not fluctuate a lot when Quince Therapeutics' options are near their expiration.
The Naive Prediction forecasted value of Quince Therapeutics on the next trading day is expected to be 1.13 with a mean absolute deviation of 0.40 and the sum of the absolute errors of 24.88. Quince Therapeutics after-hype prediction price | USD 0.14 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Quince Therapeutics to cross-verify your projections. Prediction based on Rule 16 of the current Quince contract
Based on the Rule 16, the options market is currently suggesting that Quince Therapeutics will have an average daily up or down price movement of about 0.28% per day over the life of the 2026-04-17 option contract. With Quince Therapeutics trading at USD 0.13, that is roughly USD 3.58E-4 . If you think that the market is fully incorporating Quince Therapeutics' daily price movement you should consider acquiring Quince Therapeutics options at the current volatility level of 4.41%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-04-17 Quince Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Quince Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Quince Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Quince Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Quince Therapeutics' open interest, investors have to compare it to Quince Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Quince Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Quince. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Quince Therapeutics Additional Predictive Modules
Most predictive techniques to examine Quince price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Quince using various technical indicators. When you analyze Quince charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Forecasting cash, or other financial indicators, requires analysts to apply different statistical methods, techniques, and algorithms to find hidden patterns within the Quince Therapeutics' financial statements to predict how it will affect future prices.
Cash | First Reported 2018-03-31 | Previous Quarter 16.8 M | Current Value 6.5 M | Quarterly Volatility 26.8 M |
Quince Therapeutics Naive Prediction Price Forecast For the 27th of February
Given 90 days horizon, the Naive Prediction forecasted value of Quince Therapeutics on the next trading day is expected to be 1.13 with a mean absolute deviation of 0.40, mean absolute percentage error of 0.29, and the sum of the absolute errors of 24.88.Please note that although there have been many attempts to predict Quince Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Quince Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Quince Therapeutics Stock Forecast Pattern
| Backtest Quince Therapeutics | Quince Therapeutics Price Prediction | Research Analysis |
Quince Therapeutics Forecasted Value
In the context of forecasting Quince Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Quince Therapeutics' downside and upside margins for the forecasting period are 0 and 44.56, respectively. We have considered Quince Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Quince Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Quince Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 118.7251 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.4012 |
| MAPE | Mean absolute percentage error | 1.0719 |
| SAE | Sum of the absolute errors | 24.877 |
Predictive Modules for Quince Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Quince Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Quince Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Quince Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Quince Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Quince Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Quince Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Quince Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Quince Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Quince Therapeutics' historical news coverage. Quince Therapeutics' after-hype downside and upside margins for the prediction period are 0.01 and 43.56, respectively. We have considered Quince Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Quince Therapeutics is out of control at this time. Analysis and calculation of next after-hype price of Quince Therapeutics is based on 3 months time horizon.
Quince Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Quince Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Quince Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Quince Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.81 | 43.43 | 0.01 | 0.03 | 7 Events / Month | 7 Events / Month | In about 7 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.13 | 0.14 | 4.56 |
|
Quince Therapeutics Hype Timeline
Quince Therapeutics is at this time traded for 0.13. The entity has historical hype elasticity of 0.01, and average elasticity to hype of competition of 0.03. Quince is forecasted to increase in value after the next headline, with the price projected to jump to 0.14 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 4.56%, whereas the daily expected return is at this time at 0.81%. The volatility of related hype on Quince Therapeutics is about 108575.0%, with the expected price after the next announcement by competition of 0.16. Quince Therapeutics currently holds about 94.66 M in cash with (31.9 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.62, which can makes it an attractive takeover target, given it will continue generating positive cash flow. Given the investment horizon of 90 days the next forecasted press release will be in about 7 days. Check out Historical Fundamental Analysis of Quince Therapeutics to cross-verify your projections.Quince Therapeutics Related Hype Analysis
Having access to credible news sources related to Quince Therapeutics' direct competition is more important than ever and may enhance your ability to predict Quince Therapeutics' future price movements. Getting to know how Quince Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Quince Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ATYR | aTyr Pharma | (0.04) | 8 per month | 3.23 | 0.12 | 10.23 | (6.10) | 35.20 | |
| DTIL | Precision BioSciences | 0.24 | 10 per month | 0.00 | (0.12) | 5.99 | (6.79) | 15.28 | |
| IFRX | InflaRx NV | 0.02 | 7 per month | 0.00 | (0.09) | 7.23 | (8.73) | 20.54 | |
| MGX | Metagenomi Common Stock | (0.04) | 6 per month | 3.14 | (0.03) | 6.38 | (4.61) | 18.63 | |
| GUTS | Fractyl Health Common | 0.07 | 6 per month | 0.00 | (0.07) | 9.31 | (8.44) | 85.71 | |
| ALXO | Alx Oncology Holdings | 0.02 | 9 per month | 4.97 | 0.13 | 12.07 | (8.67) | 22.52 | |
| CNTB | Connect Biopharma Holdings | (0.12) | 9 per month | 0.00 | (0.05) | 8.70 | (8.00) | 23.97 | |
| ADVM | Adverum Biotechnologies | 0.00 | 8 per month | 3.70 | 0.06 | 10.34 | (6.79) | 40.97 | |
| CAMP | CAMP4 THERAPEUTICS PORATION | 0.02 | 7 per month | 7.75 | 0.06 | 12.76 | (14.21) | 47.02 | |
| KLRS | Kalaris Therapeutics | 0.23 | 7 per month | 4.67 | 0.12 | 15.58 | (8.93) | 32.75 |
Other Forecasting Options for Quince Therapeutics
For every potential investor in Quince, whether a beginner or expert, Quince Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Quince Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Quince. Basic forecasting techniques help filter out the noise by identifying Quince Therapeutics' price trends.Quince Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Quince Therapeutics stock to make a market-neutral strategy. Peer analysis of Quince Therapeutics could also be used in its relative valuation, which is a method of valuing Quince Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Quince Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Quince Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Quince Therapeutics shares will generate the highest return on investment. By undertsting and applying Quince Therapeutics stock market strength indicators, traders can identify Quince Therapeutics entry and exit signals to maximize returns.
Quince Therapeutics Risk Indicators
The analysis of Quince Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Quince Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting quince stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 13.88 | |||
| Semi Deviation | 19.23 | |||
| Standard Deviation | 41.58 | |||
| Variance | 1729.09 | |||
| Downside Variance | 435.13 | |||
| Semi Variance | 369.65 | |||
| Expected Short fall | (18.61) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Quince Therapeutics
The number of cover stories for Quince Therapeutics depends on current market conditions and Quince Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Quince Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Quince Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Quince Therapeutics Short Properties
Quince Therapeutics' future price predictability will typically decrease when Quince Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Quince Therapeutics often depends not only on the future outlook of the potential Quince Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Quince Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 43.3 M | |
| Cash And Short Term Investments | 40.8 M |
Additional Tools for Quince Stock Analysis
When running Quince Therapeutics' price analysis, check to measure Quince Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quince Therapeutics is operating at the current time. Most of Quince Therapeutics' value examination focuses on studying past and present price action to predict the probability of Quince Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quince Therapeutics' price. Additionally, you may evaluate how the addition of Quince Therapeutics to your portfolios can decrease your overall portfolio volatility.